Lilly adds to pain pipeline with Asahi Kasei licensing dealUS drugmaker Eli Lilly – still waiting for an FDA decision on one non-opioid pain drug – has Share XLilly adds to pain pipeline with Asahi Kasei licensing dealhttps://pharmaphorum.com/news/lilly-adds-to-pain-pipeline-with-asahi-kasei-licensing-deal/
Registration opens for SMi’s leading Pain Therapeutics ConferenceRegistration opens for Pain Therapeutics Share XRegistration opens for SMi’s leading Pain Therapeutics Conferencehttps://pharmaphorum.com/partner-content/registration-opens-for-smis-leading-pain-therapeutics-conference/
Pain Therapeutics conference is taking place in London next weekSMi Group reports: To reserve last available seats at the Pain Therapeutics Conference, head on to the event Share XPain Therapeutics conference is taking place in London next weekhttps://pharmaphorum.com/partner-content/pain-therapeutics-conference-is-taking-place-in-london-next-week/
Over 20 presentations on developments in the field of analgesic medicineSMi Group reports: Pain Therapeutics conference is a one-stop shop to discover all of the cutting-edge news, updates Share XOver 20 presentations on developments in the field of analgesic medicinehttps://pharmaphorum.com/partner-content/over-20-presentations-on-developments-in-the-field-of-analgesic-medicine/
Pain Therapeutics industry updates at the SMi event in MaySMi’s Pain Therapeutics Conference (London, 21 – 22 May) brings together decision makers and creative thinkers to unite Share XPain Therapeutics industry updates at the SMi event in Mayhttps://pharmaphorum.com/partner-content/pain-therapeutics-industry-updates-at-the-smi-event-in-may/